Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Nastech enters into supply agreement with P&G for PTH (1-34) nasal spray

June 9, 2006

Competact for type 2 diabetes recommended for approval in Europe

June 8, 2006

Merck & Co. brings forward anticipated NDA filing for MK-0431A

June 8, 2006

Orphan drug designation for Xechem's 5-HMF in sickle cell disease

June 8, 2006

Recent patents describe new treatments for endocrine-related disorders

June 8, 2006

Phase III safety study of AIR insulin completes enrollment

June 8, 2006

CXCL7-derived peptide improves bone density and strength in preclinical studies

June 7, 2006

Eltrombopag safe and effective in increasing platelet counts in humans

June 7, 2006

Tibolone NDA deemed not approvable

June 7, 2006

Priority review for Gestiva NDA

June 7, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 18, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...